Cross Research S.a.: Clinical Trials

4 trials sponsored by Cross Research S.a., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow Cross Research S.a.: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome
RP101 - Dry Eye Syndromes
Phase 2CompletedRedwood Pharma AB1042019-01-182019-12-20
Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures
30 mg Paracetamol 3% (1 mL), 60 mg Paracetamol 3% (2 mL), 90 mg Paracetamol 3% (3 mL) - Pain, Postoperative
Phase 2CompletedSintetica SA602018-08-062021-06-24
Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye
rhNGF 20 µg/mL, rhNGF 4 µg/mL - Dry Eye Syndrome
Phase 2CompletedDompé Farmaceutici S.p.A402014-01-202024-04-19
Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy
dimiracetam, sugar pill - Neuropathy, AIDS
Phase 2CompletedNeurotune AG1162009-10-012010-06-02

Conditions studied

Dry Eye Syndromes (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Keratoconjunctivitis Sicca (1)  ·  Neuralgia (1)  ·  Pain, Postoperative (1)

Interventions

Acetaminophen (1)  ·  Injections (1)  ·  Saline Solution (1)  ·  Solutions (1)  ·  Sugars (1)  ·  cenegermin (1)  ·  dimiracetam (1)

Countries

Austria (2)  ·  Germany (1)  ·  Hungary (1)  ·  South Africa (1)  ·  Switzerland (1)

Top investigators

Claudio Camponovo, MD (1)  ·  Daniel R Malan, MD (1)  ·  Ruggero G Fariello, MD FAAN (1)

Results publications

PMID 30944103, PMID 33710587